Measurement Issues in Trials of Pediatric Acute Diarrheal Diseases: A Systematic Review

Department of Clinical Epidemiology and Biostatistics, McMaster University, Health Sciences Centre, Hamilton, Ontario, Canada.
PEDIATRICS (Impact Factor: 5.47). 07/2010; 126(1):e222-31. DOI: 10.1542/peds.2009-3667
Source: PubMed

ABSTRACT Worldwide, diarrheal diseases rank second among conditions that afflict children. Despite the disease burden, there is limited consensus on how to define and measure pediatric acute diarrhea in trials.
In RCTs of children involving acute diarrhea as the primary outcome, we documented (1) how acute diarrhea and its resolution were defined, (2) all primary outcomes, (3) the psychometric properties of instruments used to measure acute diarrhea and (4) the methodologic quality of included trials, as reported.
We searched CENTRAL, Embase, Global Health, and Medline from inception to February 2009. English-language RCTs of children younger than 19 years that measured acute diarrhea as a primary outcome were chosen.
We identified 138 RCTs reporting on 1 or more primary outcomes related to pediatric acute diarrhea/diseases. Included trials used 64 unique definitions of diarrhea, 69 unique definitions of diarrhea resolution, and 46 unique primary outcomes. The majority of included trials evaluated short-term clinical disease activity (incidence and duration of diarrhea), laboratory outcomes, or a composite of these end points. Thirty-two trials used instruments (eg, single and multidomain scoring systems) to support assessment of disease activity. Of these, 3 trials stated that their instrument was valid; however, none of the trials (or their citations) reported evidence of this validity. The overall methodologic quality of included trials was good.
Even in what would be considered methodologically sound clinical trials, definitions of diarrhea, primary outcomes, and instruments employed in RCTs of pediatric acute diarrhea are heterogeneous, lack evidence of validity, and focus on indices that may not be important to participants.

Download full-text


Available from: Bradley C Johnston, Sep 27, 2015
463 Reads
  • Source
    • "8 These symptoms overlap with the diagnosis of acute gastroenteritis (AGE), an infectious illness characterized by acute diarrhoea, with or without nausea, vomiting, fever , and abdominal pain. 9 A systematic review by Johnston et al. performed in 2010 highlighted 64 unique definitions and 46 unique primary outcomes used in randomized controlled trials involving paediatric diarrhoea. 10 This presents a challenge to clinicians, requiring increased attentiveness when applying evidence-based decision rules to practice. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The worldwide burden of diarrhoeal disease results in 1.5 million deaths annually in children under the age of five. Emergency physicians are often the primary medical provider to care for these children, so a firm understanding of diarrhoeal aetiology, microbiology, risk stratification, and treatment options is crucial. By using a focused history and physical exam with appropriately targeted serum investigations and imaging studies, children may be accurately assessed for degree of dehydration. Ultrasound imaging in particular is emerging as a rapid and reliable tool for this purpose. While oral rehydration remains essential first-line treatment, more severe presentations warrant use of intravenous crystalloid for the correction of fluid deficit. A focus on proper patient disposition and discharge instructions is also critical for prevention of further morbidity and to prevent unnecessary emergency centre returns. This overview of recent literature provides the emergency physician with a basic understanding of the evidence supporting management of paediatric diarrhoea.
    06/2013; 3(2):75–82. DOI:10.1016/j.afjem.2012.06.004
  • [Show abstract] [Hide abstract]
    ABSTRACT: To highlight recent advances in our understanding of prolonged episodes of acute diarrhea and persistent diarrhea in children. The focus is on the contribution of these illnesses to the global burden of diarrhea, their impact on childhood growth and development, novel epidemiologic links between prolonged and persistent diarrheal episodes, and strategies for their prevention and management. Although less common than acute diarrhea, prolonged and persistent episodes of diarrhea in childhood constitute a significant portion of the global burden of diarrhea. These episodes also play a key role in the vicious cycle of childhood diarrhea and malnutrition in which undernutrition is both a risk factor and an outcome of diarrhea. Increased efforts to provide WHO-recommended zinc therapy for all children with diarrhea in developing countries will significantly reduce morbidity and mortality. In children who develop persistent diarrhea, yogurt-based or amino acid-based diets may accelerate their recovery. In addition to increased implementation of strategies already known to effectively prevent and manage acute diarrhea, further research is needed to address the recognition, prevention, and treatment of prolonged episodes of acute diarrhea and persistent diarrhea in resource-limited settings.
    Current opinion in gastroenterology 01/2011; 27(1):19-23. DOI:10.1097/MOG.0b013e32833f215d · 4.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to examine the effects of a follow-on formula containing Lactobacillus fermentum CECT5716 (L. fermentum) on the incidence of infections in infants between the ages of 6 and 12 months. A randomized double-blinded controlled study including infants at the age of 6 months was conducted. Infants were assigned randomly to either follow-on formula supplemented with L. fermentum plus galactooligosaccharide (experimental group, EG), or the same formula supplemented with only galactooligosaccharide (control group, CG). The main outcome was the incidence of infections for the 6-month duration of the study. The EG showed a significant 46% reduction in the incidence rate (IR) of gastrointestinal infections (EG: 0.196 ± 0.51, CG: 0.363 ± 0.53, IR ratio 0.54, 95% confidence interval [CI] 0.307-0.950, P = 0.032), 27% reduction in the incidence of upper respiratory tract infections (EG: 0.969 ± 0.96, CG: 1.330 ± 1.23, IR ratio 0.729, 95% CI 0.46-1.38, P = 0.026), and 30% reduction in the total number of infections (EG: 1.464 ± 1.15, CG: 2.077 ± 1.59, IR ratio 0.70, 95% CI 0.46-1.38, P = 0.003), at the end of the study period compared with CG. Administration of a follow-on formula with L. fermentum CECT5716 may be useful for the prevention of community-acquired gastrointestinal and upper respiratory infections.
    Journal of pediatric gastroenterology and nutrition 08/2011; 54(1):55-61. DOI:10.1097/MPG.0b013e3182333f18 · 2.63 Impact Factor
Show more